Subsidy Tracker Parent Company Summary
Parent Company Name:
Teva Pharmaceutical Industries
Ownership Structure:
publicly traded (ticker symbol TEVA)
Headquartered in:
Israel
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
|---|---|---|
| State/Local | $71,321,196 | 42 |
| Federal (grants and allocated tax credits) | $0 | 0 |
| TOTAL | $71,321,196 | 42 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards:
Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2011.
Time Period for Federal Awards:
FY2000 to the present
Notes:
Dollar totals do not include awards for which no subsidy value is disclosed.
Links:
For a summary of this company's regulatory violations see its Violation Tracker summary page here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
|---|---|---|
| New Jersey | $41,967,930 | 2 |
| Pennsylvania | $22,331,821 | 21 |
| Kansas | $3,966,515 | 4 |
| Utah | $1,683,200 | 1 |
| Virginia | $900,000 | 2 |
| All other | $471,730 | 12 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Download results as 
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
| Company | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|
| Teva Pharmceuticals USA Inc. | New Jersey | State | 2018 | $39,998,730 | tax credit/rebate | |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2014 | $6,118,950 | tax credit/rebate | |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2013 | $5,485,485 | tax credit/rebate | |
| Cephalon, Inc. | Pennsylvania | state | $4,000,000 | grant | ||
| Teva Pharmaceuticals | Kansas | state | 2014 | $3,861,454 | grant | |
| Barr Laboratories, Inc. and Subsidiaries | New Jersey | state | 2002 | $1,969,200 | grant | |
| Cephalon, Inc. | Pennsylvania | state | $1,749,000 | tax credit/rebate | ||
| Cephalon | Utah | state | 2009 | $1,683,200 | tax credit/rebate | |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2012 | $903,866 | tax credit/rebate | |
| Cephalon, Inc. | Pennsylvania | state | 2011 | $740,231 | tax credit/rebate | |
| Teva Branded Pharmaceutical Products R&D, Inc. | Pennsylvania | state | 2011 | $566,948 | tax credit/rebate | |
| Barr Laboratories Inc. | Virginia | state | 2008 | $500,000 | grant | |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | $405,000 | tax credit/rebate | ||
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | $400,000 | grant | ||
| Barr Laboratories, Inc. | Virginia | state | 2008 | $400,000 | grant | |
| Nupathe, Inc. | Pennsylvania | state | 2008 | $369,626 | tax credit/rebate | |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | $345,000 | tax credit/rebate | ||
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2010 | $241,071 | tax credit/rebate | |
| Nupathe, Inc. | Pennsylvania | state | 2009 | $206,194 | tax credit/rebate | |
| NuPathe, Inc. | Pennsylvania | state | 2011 | $161,044 | tax credit/rebate | |
| TEVA Pharmaceuticals USA | Pennsylvania | state | $150,000 | training reimbursement | ||
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2009 | $145,313 | tax credit/rebate | |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2017 | $137,235 | tax credit/rebate | |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2012 | $129,362 | tax credit/rebate | |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2016 | $76,366 | tax credit/rebate | |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2008 | $76,270 | tax credit/rebate | |
| Nupathe, Inc. | Pennsylvania | state | 2010 | $54,157 | tax credit/rebate | |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2015 | $53,885 | tax credit/rebate | |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2012 | $50,570 | tax credit/rebate | |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2014 | $50,570 | tax credit/rebate | |
| Teva Biopharmaceuticals, Inc. | Maryland | state | 2010 | $42,015 | tax credit/rebate | |
| TEVA Biopharmaceuticals, Inc. | Maryland | state | 2009 | $41,319 | tax credit/rebate | |
| Teva Pharmaceuticals | Kansas | local | 2017 | $37,036 | tax credit/rebate | |
| Teva Pharmaceuticals | Kansas | local | 2018 | $36,371 | tax credit/rebate | |
| Teva Pharmaceuticals | Kansas | local | 2016 | $31,654 | tax credit/rebate | |
| Teva Biopharmaceuticals USA, Inc. | Maryland | state | 2017 | $30,972 | tax credit/rebate | |
| TEVA Biopharmaceuticals, Inc. | Maryland | state | 2011 | $26,524 | tax credit/rebate | |
| Ivax Pharmaceuticals | New York | local | 2008 | $13,095 | tax credit/rebate; property tax abatement | |
| NuPathe, Inc. | Pennsylvania | state | 2012 | $12,593 | tax credit/rebate | |
| Teva Pharmaceuticals USA, Inc. | Pennsylvania | state | 2011 | $10,746 | tax credit/rebate | |
| IVAX PHARMACEUTICALS | New York | local | 2005 | $5,214 | tax credit/rebate; property tax abatement | |
| Ivax Pharmaceuticals | New York | local | 2007 | $4,930 | tax credit/rebate; property tax abatement | |
| ACTAVIS ELIZABETH LLC | New Jersey | state | undisclosed | tax credit/rebate; property tax abatement | ||
| ACTAVIS ELIZABETH LLC | New Jersey | state | undisclosed | tax credit/rebate; property tax abatement | ||
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2016 | undisclosed | grant | |
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2017 | undisclosed | grant | |
| Teva Pharmaceuticals USA, Inc. | Kansas | state | 2018 | undisclosed | grant |
Download results as or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
or XML (maximum 10,000; for access to larger downloads contact Kasia Tarczynska)
